Recent news on

Medicis Reports First Quarter 2007 Financial Results  -  May 8, 2007
Primenewswire (press release),The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl),

Medicis making itself a new home in Scottsdale  -  Apr 13, 2007
East Valley Tribune,...giants and has established its dominance in dermatological drugs with such market leaders as Dynacin, Triaz, Omnicef, Vanos and new product Solodyn.

Medicis Reports Fourth Quarter and Year End 2006 Financial Results  -  Feb 28, 2007
Primenewswire (press release),The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox),

Medicis Announces 2006 Fourth Quarter and Year-End Conference Call ...  -  Feb 26, 2007
Primenewswire (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir),

Medicis to Present At Roth Capital Partners 19th Annual OC Conference  -  Feb 15, 2007
PharmaLive.com (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir),

Medicis to Present At JPMorgan 25th Annual Healthcare Conference  -  Jan 4, 2007
PharmaLive.com (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir),

Medicis Declares Cash Dividend  -  Dec 14, 2006
Primenewswire (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir),

Medicis and Dow Pharmaceutical Sciences Announce FDA Approval of ...  Nov 7, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... -PrimeZone (press release), Market Report -- Short Stories (MRX)  Oct 19, 2006
...with its Restylane and Reloxin (2008) product offerings, while maintaining a strong presence in the acne category with its Solodyn, Dynacin, Plexion, and Triaz ... -MSN Money Medicis to Present at UBS Global Life Sciences Conference  Sep 22, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... -PrimeZone

Medicis to Present at Credit Suisse Healthcare Conference  -  Nov 13, 2006
PharmaLive.com (press release),The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir),

Medicis Reports Second Quarter 2006 Financial Results  Aug 2, 2006
At the end of the June 2006 quarter, the Company's core brands included DYNACIN(R), LOPROX(R), OMNICEF(R), PLEXION(R), RESTYLANE(R), SOLODYN(TM), TRIAZ(R) and ... -PrimeZone

Medicis reports revenue down  Aug 3, 2006
The product should spur significant sales in the future, possibly stealing shares from the company’s own core product Dynacin, Shacknai said. ... -East Valley Tribune

Medicis Announces Second Quarter 2006 Conference Call and Webcast  Jul 31, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... -PrimeZone

Medicis seeking more space  22 Jul 2006
The country’s leading independent dermatological products company, Medicis made its name in prescription products, such as the acne treatment Dynacin. ... -East Valley Tribune

Medicis Names Jason Hanson Executive Vice President and General ...  Jul 12, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... -PrimeZone

Euronext Paris) - Ipsen : Medicis and Ipsen decide to focus ...  Jul 12, 2006
The Company's products include the prescription brands RESTYLANE®, DYNACIN® (minocycline HCl), LOPROX® (ciclopirox), OMNICEF® (cefdinir), PLEXION® (sodium ... -Euronext (persbericht)



Medicis Reports First Quarter 2006 Financial Results  May 9, 2006
...in the March 2006 quarter primarily is attributable to a reduction in contract revenue of $15.3 million and continued generic erosion of the DYNACIN(R) and ... - PrimeZone

Medicis reports $88.5 million loss  May 10, 2006
Jonah Shacknai chalked that up to an expected reduction in contract revenue and the rise of generic alternatives for Medicis core products Dynacin and Loprox. ... - East Valley Tribune

Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP ...  May 8, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - PharmaLive.com





(PZ) Medicis Reports December 2005 Financial Results  Mar 15, 2006
Dow"); -- $9.2 million ($5.9 million tax-effected) special charge associated with the write-down of an intangible asset associated with DYNACIN(R) Capsules ... - Houston Chronicle

Medicis reports quarterly profit up but revenue down  Mar 16, 2006
...slip in quarterly revenue was caused by new generic competition for two of the company’s top products — longtime industry leaders Dynacin and Loprox ... - East Valley Tribune

Medicis 4Q Profit Jumps on Hefty Gain  Mar 15, 2006
The company said it continues to experience erosion in its Dynacin (oral antibiotic for acne) and Loprox (antifungal medication) franchises due to generic ... - Houston Chronicle

Medicis Declares Cash Dividend  Mar 15, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - PrimeZone

UPDATE 2-Medicis operating profit, revenue fall  Mar 15, 2006
Revenue shrank on competition from cheaper generic versions of Medicis' Dynacin acne drug and Loprox medicated shampoo for scalp irritation. - Reuters

Medicis Shares Could Get Boost From Near-Term Catalysts  Mar 16, 2006
...us to believe that the company bled down inventory in the channel, possibly in anticipation of an upcoming launch of a new version of Dynacin," Trbovich wrote ... - Forbes

Medicis to Present at Merrill Lynch 17th Annual Global ...  Feb 3, 2006
The Company's products include the prescription brands RESTYLANE(R), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), OMNICEF(R) (cefdinir), PLEXION(R ... - Genetic Engineering News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional